Search

Home > OncLive® On Air > 50: FDA Approval Insights: Selinexor in Relapsed/Refractory DLBCL
Podcast: OncLive® On Air
Episode:

50: FDA Approval Insights: Selinexor in Relapsed/Refractory DLBCL
Category: Science & Medicine
Duration: 00:08:11
Publish Date: 2020-10-26 20:50:17
Description: In our exclusive interview, Brian T. Hill, MD, PhD, provides perspective on the FDA approval of selinexor in DLBCL.
Total Play: 0

Some more Podcasts by Audioboom

70+ Episodes
Faith Moveme ..    
100+ Episodes
Videnskab.dk .. 5     1
20+ Episodes
Vidensselska ..    
10+ Episodes
Odd Jobs    
20+ Episodes
Aaron and Ga ..    
100+ Episodes
Ladies of Li .. 4     3
100+ Episodes
Chamber Podc ..    
10+ Episodes
IT'S A GROWN ..